GMG

Clinical trials for GMG explained in plain language.

Never miss a new study

Get alerted when new GMG trials appear

Sign up with your email to follow new studies for GMG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 3 Completed 1

New dosing strategy tested for muscle-weakening disease

Disease control Completed

This study tested whether giving a medication called efgartigimod continuously or in cycles works better for people with generalized myasthenia gravis, a condition that causes muscle weakness. The trial involved 69 adults who received the medication for up to 138 weeks. Researche…

Matched conditions: GMG

Phase: PHASE3 • Sponsor: argenx • Aim: Disease control

Last updated Mar 24, 2026 12:01 UTC

GMG

Get alerted when new GMG trials appear

New dosing strategy tested for muscle-weakening disease